Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Sep 22, 2025

Author Spotlight: Demonstrating Systematic Endobronchial Ultrasound to New Endoscopists
05:22

Author Spotlight: Demonstrating Systematic Endobronchial Ultrasound to New Endoscopists

Published on: August 11, 2023

2.3K

Implementing Lung Cancer Screening in Europe: Taking a Systems Approach.

Suzanne Wait1, Arturo Alvarez-Rosete1, Tasnime Osama1

  • 1The Health Policy Partnership, London, United Kingdom.

JTO Clinical and Research Reports
|May 23, 2022
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recruitment strategies for lung cancer screening; a randomised trial in the 4-IN-THE-LUNG-RUN study.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Benchmarking of AI and Radiologists for Indeterminate Lung Nodule Malignancy Risk Estimation on Screening CT: The LUNA25 Challenge.

Radiology. Artificial intelligence·2026
Same author

First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors.

Journal for immunotherapy of cancer·2026
Same author

Smoking-Related Comorbidities Detected Through Low-Dose CT Imaging Lung Cancer Screening: Current Evidence and Future Directions.

Chest·2026
Same author

Characteristics of lung nodules detected by low-dose CT scan: Results from the French lung cancer screening study DEP KP-80.

Respiratory medicine and research·2026
Same author

How to Translate Quality Standards Into Good Lung Cancer Screening Programmes: The UK Experience.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, <i>EGFR</i> Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial.

JTO clinical and research reports·2026
Same journal

Differential Treatment Effects by Smoking Status for NSCLC Therapies (2010-2023): A Meta-Analysis.

JTO clinical and research reports·2026
Same journal

Lung Adenocarcinoma Developing Pleomorphic Carcinoma With <i>ERBB3</i> Amplification After Acquired Resistance to Sotorasib: A Case Report.

JTO clinical and research reports·2026
Same journal

Phase II Trial of First-Line Durvalumab and Chemotherapy in Patients With Extra-Pulmonary Small Cell Carcinoma.

JTO clinical and research reports·2026
Same journal

Brief Report: Real-World Comparative Effectiveness of First-Line Immune Checkpoint Inhibitor Monotherapy Versus Chemo-Immunotherapy in Metastatic NSCLC With PD-L1 More Than or Equal to 50%: A Meta-Analysis.

JTO clinical and research reports·2026
Same journal

Brief Report: Impact of PLCOm2012 Ethnicity Model Variations on Eligibility for the Alberta Lung Cancer Screening Program.

JTO clinical and research reports·2026
See all related articles
This summary is machine-generated.

Implementing lung cancer screening programs using low-dose computed tomography (LDCT) requires addressing system factors like data infrastructure and equitable recruitment. Successful programs can reduce lung cancer mortality across Europe.

Area of Science:

  • Public Health
  • Oncology
  • Health Systems Research

Background:

  • Lung cancer is the leading cause of cancer death in Europe.
  • Low-dose computed tomography (LDCT) screening can detect lung cancer earlier and reduce mortality in high-risk individuals.
  • Currently, only a few European countries are implementing large-scale LDCT screening programs.

Purpose of the Study:

  • To evaluate key factors for successful implementation of lung cancer screening programs across Europe using a health systems approach.
  • To identify potential barriers and facilitators for widespread LDCT screening adoption.

Main Methods:

  • A literature review of LDCT screening in 10 European countries.
  • 17 semistructured interviews with local experts.
  • Mapping research findings against an adapted health systems framework.
Keywords:
Computed tomographyEarly detectionLung cancerPolicyScreening

More Related Videos

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting
04:47

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting

Published on: June 23, 2023

2.8K
Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

7.3K

Related Experiment Videos

Last Updated: Sep 22, 2025

Author Spotlight: Demonstrating Systematic Endobronchial Ultrasound to New Endoscopists
05:22

Author Spotlight: Demonstrating Systematic Endobronchial Ultrasound to New Endoscopists

Published on: August 11, 2023

2.3K
Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting
04:47

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting

Published on: June 23, 2023

2.8K
Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

7.3K

Main Results:

  • European policy landscapes for lung cancer screening are highly variable.
  • Common barriers to implementation exist across countries, similar to other cancer screening programs.
  • Essential system factors include data infrastructure, equitable recruitment, workforce capacity, integration with care pathways, and smoking cessation support.

Conclusions:

  • Effective, efficient, and equitable lung cancer screening programs require a comprehensive health systems approach.
  • Addressing system-level factors and societal perceptions is crucial for successful implementation.
  • Governments have an opportunity to curb lung cancer impact through adapted screening programs.